RSS

Association of the British Pharmaceutical Industry (ABPI)

In the run up to the UK’s general election, the Association of the British Pharmaceutical Industry (ABPI) is calling on political parties to support the country’s science and research industry. Read more

News

Urgent medicines will be delivered up to 48 hours after a no-deal Brexit thanks to contracts signed with three companies, the government has confirmed. Read more

News

The government has published documentation outlining preparations for a no deal Brexit, which includes how it could affect the supply chain for medicines and medical products. Read more

News

Public Health England has released its review into prescribed medicines, acknowledging that a lot of recommendations may have already started or will do shortly – partly because of what prompted the review or knowledge of the review itself. Read more

News

The Association of the British Pharmaceutical Industry (ABPI) has called on the government to make the UK the best place to develop medicines of the future. Read more

News

Spending into UK research and development by the pharmaceutical industry has increased, new figures show. Read more

News

A new collaborative initiative has been launched to help Northern Ireland’s life sciences sector thrive. Read more

News

A new president of the Association of British Pharmaceutical Industry (ABPI) has been named to help bring new medicines to patients faster. Read more

News

Life sciences could have one of the biggest impacts on the UK economy by 2025, bringing in an additional £8.5 billion of growth, according to new research. Read more

News

This week (16 January) saw prime minister Theresa May’s Brexit deal firmly defeated in the House of Commons bringing forward the very real possibility of a ‘no deal’ Brexit. Read more

News

Brexit negotiators have a duty to protect millions of patients on both sides of the Channel, a coalition from the UK’s health sector has said. Read more

News

The Association of the British Pharmaceutical Industry (ABPI) has responded to the Withdrawal Agreement, marking it as an "important step" towards securing a Brexit deal. Read more

News

Professor Carole Longson, chief scientific officer at the Association of the British Pharmaceutical Industry discusses the lack of female representation in STEM and why a woman in science is needed on the new £50 note. Read more

Opinion

The chief executive of the Association of the British Pharmaceutical Industry (ABPI) will tell the House of Commons DExEU Select Committee how they are preparing for a ‘No Deal’ Brexit. Read more

News

Following a speech from the secretary of state, Dominic Raab, on the steps that government as well as business and the public sector should be taking in case of a ‘no-deal’ scenario for Brexit, we take a look at some of the responses from industry… Read more

News

Here, Dr Sheuli Porkess, deputy chief scientific officer, Association of the British Pharmaceutical Industry (ABPI), outlines how the pharmaceutical industry takes a substance from molecule to medicine and how the process requires persistence. Read more

Opinion

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

A new report from the Office of Health Economics (OHE) — commissioned by the Association of the British Pharmaceutical Industry (ABPI) — has revealed what health leaders believe to be the ten most important medicines in NHS history. Read more

News

The Association of the British Pharmaceutical Industry (ABPI) has responded to the recent publication of the Medicines and Healthcare products Regulatory Agency (MHRA) technical guidance on what the Brexit implementation means for life sciences. Read more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News